SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biogen
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1686 75 0 BIIB
Emcee:  Harold Engstrom Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1586GS: Biogen Idec, Inc. (BIIB) IL/N: 3 Tysabri cases published. Significant hurdlemopgcw-6/15/2005
1585Piper : BIIB :Tysabri: Many Questions Remain Hot Comment mopgcw-6/14/2005
1584cool, thanks for sharing! Rickscaram(o)uche-5/5/2005
1583GS: Biogen Idec, Inc. EPS (FY Dec) 2005E $1.56, 2006E $1.81 In-Line/Neutral (BImopgcw-5/4/2005
1582[HD-Rituxan and Stem Cell Transplant versus NHL] >>Journal of Clinical Ontuck-3/31/2005
1581BIIB My sale probably more reflects the perils of reacting to news than of AvoneBob Rudd-3/16/2005
1580BIIB - SOLD 'You gotta know when to fold'em' Avonex is 2/3's of Bob Rudd-3/16/2005
1579Message 21120082Doc Bones-3/9/2005
1578Yeah, could be the issue, thanks. Though I seem to remember a statement to the tuck-3/9/2005
1577Isn't Bucknum the one who sold couple of weeks ago <i>without</i>tom pope-3/9/2005
1576With lawsuits coming from a couple of directions, the Chief Counsel resigns? &gtuck-3/9/2005
1575fool.comIKM-3/9/2005
1574Biogen Faces Kickback Accusation By DAVID ARMSTRONG Staff Reporter of THE WALLDoc Bones-3/8/2005
1573Comments from my brother, a doctor, whose wife has MS: The two patient's wiIKM-3/2/2005
1572>>Hibernia Southcoast Capital is stepping up to the plate with a buy!>&Icebrg-3/1/2005
1571Well, Hibernia Southcoast Capital is stepping up to the plate with a buy! The nDoc Bones-3/1/2005
1570GS: BIIB(IL/N): Tysabri sales unlikely in 2005. Limited downside at $4 above intmopgcw-3/1/2005
1569A good friend of mine sees a great doctor. w/a international reputation, that wcalgal-2/28/2005
1568GS: BIIB has voluntarily suspended shipment of Tysabri after two patients showemopgcw-2/28/2005
1567GS: BIIB (IL/N): BIIB management upbeat about potential of Tysabri 52-Week Rangmopgcw-2/3/2005
1566Several articles and editorials concerning Rituximab in lymphomas in the Early Rtuck-1/29/2005
1565SSB: Biogen Idec (BIIB, Hold, High Risk) Reporting date: Monday, February 7th,mopgcw-1/27/2005
1564SYLVIE GREGOIRE, FORMER BIOGEN EXECUTIVE VICE PRESIDENT, NAMED NEW CEO OF GLYCOFnigel bates-12/1/2004
1563Antegren Not Likely To Boost Biogen Stock <i>(sic)</i> 11.08.04, 11:nigel bates-11/8/2004
1562ANTEGREN One-Year Data from Phase III AFFIRM Study Showed Compelling Results in scaram(o)uche-11/8/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News